New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma
This article provides a review of Lanpressun®, a new formulations of latanoprost micellar nanoemulsion without benzaltonium chloride (BAK). The pharmacokinetics and pharmacodynamics of new formulations are presented. Due to innovative delivery system and absence of detergent preseravative (BAK, poli...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2024-06-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/2376 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849687544730484736 |
|---|---|
| author | A. S. Dukhanin A. Sh. Zagidullina G. A. Azamatova |
| author_facet | A. S. Dukhanin A. Sh. Zagidullina G. A. Azamatova |
| author_sort | A. S. Dukhanin |
| collection | DOAJ |
| description | This article provides a review of Lanpressun®, a new formulations of latanoprost micellar nanoemulsion without benzaltonium chloride (BAK). The pharmacokinetics and pharmacodynamics of new formulations are presented. Due to innovative delivery system and absence of detergent preseravative (BAK, poliquaternium and others) Lanpressun® possess better tolerability and safety to ocular surface, that provides patients adherence to longer therapy. The article presents the results of clinical trials demonstrating high hypotensive efficacy of Lanpressun®. Literature analysis of studies on safety and effect on ocular surface shows good tolerability of preservativefree latanoprost nanoemulsion. The authors give the assessment of Lanpressun® future perspectives in treatment of patients with openangle glaucoma |
| format | Article |
| id | doaj-art-bb022d2aba7f4c778a225b2eb7fc367e |
| institution | DOAJ |
| issn | 1816-5095 2500-0845 |
| language | Russian |
| publishDate | 2024-06-01 |
| publisher | Ophthalmology Publishing Group |
| record_format | Article |
| series | Oftalʹmologiâ |
| spelling | doaj-art-bb022d2aba7f4c778a225b2eb7fc367e2025-08-20T03:22:18ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452024-06-0121237538510.18008/1816-5095-2024-2-375-3851157New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle GlaucomaA. S. Dukhanin0A. Sh. Zagidullina1G. A. Azamatova2N.I. Pirogov Russian National Research Medical UniversityBashkir State Medical UniversityBashkir State Medical University; Branch of Clinic Bud ZdorovThis article provides a review of Lanpressun®, a new formulations of latanoprost micellar nanoemulsion without benzaltonium chloride (BAK). The pharmacokinetics and pharmacodynamics of new formulations are presented. Due to innovative delivery system and absence of detergent preseravative (BAK, poliquaternium and others) Lanpressun® possess better tolerability and safety to ocular surface, that provides patients adherence to longer therapy. The article presents the results of clinical trials demonstrating high hypotensive efficacy of Lanpressun®. Literature analysis of studies on safety and effect on ocular surface shows good tolerability of preservativefree latanoprost nanoemulsion. The authors give the assessment of Lanpressun® future perspectives in treatment of patients with openangle glaucomahttps://www.ophthalmojournal.com/opht/article/view/2376treatment of glaucomaprostaglandine analogueslatanoprostlanpressun®preservativeocular surface |
| spellingShingle | A. S. Dukhanin A. Sh. Zagidullina G. A. Azamatova New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma Oftalʹmologiâ treatment of glaucoma prostaglandine analogues latanoprost lanpressun® preservative ocular surface |
| title | New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma |
| title_full | New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma |
| title_fullStr | New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma |
| title_full_unstemmed | New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma |
| title_short | New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma |
| title_sort | new nanomicellar form of latanoprost 0 005 in treatment open angle glaucoma |
| topic | treatment of glaucoma prostaglandine analogues latanoprost lanpressun® preservative ocular surface |
| url | https://www.ophthalmojournal.com/opht/article/view/2376 |
| work_keys_str_mv | AT asdukhanin newnanomicellarformoflatanoprost0005intreatmentopenangleglaucoma AT ashzagidullina newnanomicellarformoflatanoprost0005intreatmentopenangleglaucoma AT gaazamatova newnanomicellarformoflatanoprost0005intreatmentopenangleglaucoma |